What is the Optimal Strategy for Adaptive Servo-Ventilation Therapy?

Area of Science:

• Cardiology
• Pulmonology
• Sleep Medicine

Background:

• Adaptive servo-ventilation (ASV) therapy has shown potential benefits in specific heart failure patient groups with sleep-disordered breathing.
• However, multicenter randomized trials have not consistently demonstrated these clinical advantages, highlighting a discrepancy in findings.

Purpose of the Study:

• To investigate the key factors contributing to the discrepancy in ASV therapy outcomes.
• To identify optimal patient selection criteria and device settings for successful ASV therapy in heart failure.

Main Methods:

• Review of existing literature on ASV therapy in heart failure.
• Analysis of hemodynamic and echocardiographic parameters as predictors of ASV response.
• Discussion of the role of pulmonary congestion and right ventricular dysfunction indicators.

Main Results:

• Hemodynamic and echocardiographic parameters, including elevated pulmonary capillary wedge pressure, are associated with positive responses to ASV.
• Indicators of right ventricular dysfunction have also emerged as significant predictors of good response.
• Optimal device settings, including appropriate pressure and timing, are critical for therapeutic success.

Conclusions:

• Optimal patient selection and precise device settings are likely essential for realizing the clinical benefits of ASV therapy.
• Further large-scale prospective trials are warranted to validate these findings and establish definitive protocols for ASV in heart failure management.